Bard Financial Services, Inc. Gilead Sciences, Inc. Transaction History

Bard Financial Services, Inc.

$840 Million
Q3 2024

A detailed history of Bard Financial Services, Inc. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Bard Financial Services, Inc. holds 30,095 shares of GILD stock, worth $2.75 Million. This represents 0.3% of its overall portfolio holdings.

Number of Shares

30,095

Previous 18,120 66.09%

Holding current value

$2.75 Million

Previous $1.52 Million 66.14%

% of portfolio

0.3%

Previous 0.32%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 20, 2024	BUY	$66.59 - $83.99 $797,415 - $1.01 Million	11,975 Added 66.09%	30,095 $2.52 Million
Q3 2024 Oct 04, 2024	SELL	$66.59 - $83.99 $975,543 - $1.23 Million	-14,650 Reduced 44.71%	18,120 $1.52 Million
Q2 2024 Jul 09, 2024	SELL	$63.15 - $72.88 $23,681 - $27,330	-375 Reduced 1.13%	32,770 $2.25 Million
Q1 2024 May 06, 2024	BUY	$71.58 - $87.29 $17,895 - $21,822	250 Added 0.76%	33,145 $2.43 Million
Q4 2023 Feb 09, 2024	SELL	$73.27 - $83.09 $174,016 - $197,338	-2,375 Reduced 6.73%	32,895 $2.66 Million
Q3 2023 Oct 16, 2023	BUY	$73.94 - $80.67 $20,333 - $22,184	275 Added 0.79%	35,270 $2.64 Million
Q2 2023 Jul 11, 2023	SELL	$76.01 - $86.7 $11,401 - $13,005	-150 Reduced 0.43%	34,995 $2.7 Million
Q1 2023 Apr 26, 2023	SELL	$77.31 - $88.08 $57,982 - $66,060	-750 Reduced 2.09%	35,145 $2.92 Million
Q4 2022 Jan 25, 2023	SELL	$62.32 - $89.47 $31,160 - $44,735	-500 Reduced 1.37%	35,895 $3.08 Million
Q3 2022 Oct 26, 2022	BUY	$59.54 - $68.01 $58,051 - $66,309	975 Added 2.75%	36,395 $2.25 Million
Q2 2022 Jul 06, 2022	SELL	$57.72 - $65.01 $69,264 - $78,012	-1,200 Reduced 3.28%	35,420 $2.19 Million
Q1 2022 Apr 13, 2022	BUY	$57.92 - $72.58 $44,888 - $56,249	775 Added 2.16%	36,620 $2.18 Million
Q4 2021 Jan 24, 2022	BUY	$64.88 - $73.64 $11,354 - $12,887	175 Added 0.49%	35,845 $2.6 Million
Q3 2021 Oct 15, 2021	BUY	$67.69 - $73.03 $8,461 - $9,128	125 Added 0.35%	35,670 $2.49 Million
Q2 2021 Jul 13, 2021	BUY	$63.47 - $69.35 $63,470 - $69,350	1,000 Added 2.89%	35,545 $2.45 Million
Q4 2020 Mar 26, 2021	BUY	$56.65 - $64.55 $1.96 Million - $2.23 Million	34,545 New	34,545 $2.01 Million

Others Institutions Holding GILD

# of Institutions

1,927

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $114B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bard Financial Services, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Bard Financial Services, Inc. with notifications on news.

Account

Bard Financial Services, Inc. Gilead Sciences, Inc. Transaction History